MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$48,971K
Net Income
-$10,255K
Net Profit Margin
-20.94%
EPS
-$0.2
Unit: Thousand (K) dollars
Revenue Breakdown
Biologistics Solutions
Product
Biostorage Bioservices
Revenue Breakdown
Americas
EMEA
Asia Pacific
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
48,971
47,798
45,450
44,233
Service
14,008
13,747
13,548*
12,201
Product
12,139
12,138
10,192*
10,707
Total cost of revenue
26,147
25,885
23,739
22,908
Gross margin
22,824
21,913
21,711
21,325
Selling, general and administrative
28,011
27,620
24,986
26,734
Engineering and development
4,852
3,907
4,466
4,523
Total operating costs and expenses
32,863
31,527
29,452
31,257
Loss from operations
-10,039
-9,614
-7,741
-9,932
Investment income
3,132
3,090
3,357
3,402
Interest expense, net
518
432
634
526
Other expense, net
-325
-2,368
-87
525
Total other income (expense), net
2,289
290
2,636
3,401
Loss from continuing operations before provision for income taxes
-7,750
-9,324
-5,105
-6,531
Provision for income taxes
505
108
1,126
165
Loss from continuing operations
-8,255
-9,432
-6,231
-6,696
Gain from discontinued operations, net
-
-1,112
-1,724
-247
Net income (gain)
-8,255
-10,544
-7,955
-6,943
Paid-in-kind dividend on series c convertible preferred stock
2,000
2,000
2,000
2,000
Net income (gain) attributable to common stockholders
-10,255
-12,544
-9,955
-8,943
Basic EPS
-0.2
-0.25
-0.199
-0.18
Diluted EPS
-0.2
-0.25
-0.199
-0.18
Basic Average Shares
50,442,796
49,897,817
49,957,268
50,125,268
Diluted Average Shares
50,442,796
49,897,817
49,957,268
50,125,268
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Net income (gain)
attributable to common...
-$10,255K
(-109.94%↓ Y/Y)
Net income (gain)
-$8,255K
(-107.85%↓ Y/Y)
Paid-in-kind dividend on
series c convertible...
$2,000K
(0.00%↑ Y/Y)
Biologistics Solutions
$22,359K
(12.50%↑ Y/Y)
Biostorage Bioservices
$5,610K
(24.81%↑ Y/Y)
Loss from continuing
operations
-$8,255K
(31.29%↑ Y/Y)
Investment income
$3,132K
(113.64%↑ Y/Y)
Service
$27,969K
(14.77%↑ Y/Y)
Product
$21,002K
(-0.39%↓ Y/Y)
Loss from continuing
operations before...
-$7,750K
(33.99%↑ Y/Y)
Provision for income taxes
$505K
(84.31%↑ Y/Y)
Total other income
(expense), net
$2,289K
(209.47%↑ Y/Y)
Total revenue
$48,971K
(7.74%↑ Y/Y)
Interest expense, net
$518K
(-16.18%↓ Y/Y)
Other expense, net
-$325K
(88.94%↑ Y/Y)
Loss from operations
-$10,039K
(-4.04%↓ Y/Y)
Gross margin
$22,824K
(6.77%↑ Y/Y)
Total cost of revenue
$26,147K
(8.60%↑ Y/Y)
Total operating costs
and expenses
$32,863K
(5.92%↑ Y/Y)
Service
$14,008K
(12.52%↑ Y/Y)
Product
$12,139K
(4.39%↑ Y/Y)
Selling, general and
administrative
$28,011K
(4.10%↑ Y/Y)
Engineering and development
$4,852K
(17.82%↑ Y/Y)
Buy us a coffee
Cryoport, Inc. (CYRX)
Cryoport, Inc. (CYRX)